Business EconomyPosted at: Nov 4 2026 8:29PM


Aurobindo Pharma Q2 net profit rises 32.5 pc to Rs 1,124 crore

Hyderabad, Nov 4 (UNI) Aurobindo Pharma Limited on Wednesday reported a 32.5 per cent year-on-year increase in consolidated net profit to Rs 1,124 crore for the second quarter ended September 30, 2026, compared to Rs 848 crore in the corresponding quarter last fiscal.
The company's revenue from operations rose 23.9 per cent to Rs 10,263 crore from Rs 8,286 crore in the year-ago period, marking its highest-ever quarterly revenue.
EBITDA, before forex and other income, increased 28.5 per cent to Rs 2,156 crore, while the EBITDA margin improved to 21 per cent from 20.3 per cent in the corresponding quarter last year, Hyderabad based pharma said in a release here.
Revenue from the US market grew 25 per cent year-on-year to Rs 4,555 crore, while Europe revenue increased 27 per cent to Rs 3,161 crore. Growth Markets revenue rose 16 per cent to Rs 1,026 crore. Anti-retroviral (ARV) revenue stood at Rs 359 crore.
The company received final approval from the US Food and Drug Administration (USFDA) for 12 products during the quarter.
Its research and development expenditure stood at Rs 376 crore.
Aurobindo generated free cash flows of USD 146 million during the quarter after accounting for strategic capital expenditure and reported a net cash position, including investments, of USD 189 million as on September 30, 2026.
The company also declared an interim dividend of Rs 7 per share. Basic and diluted earnings per share stood at Rs 19.57.
Commenting on the results, Vice-Chairman and Managing Director K Nithyananda Reddy said the performance reflected strong business fundamentals, sustained execution and resilience of its diversified product portfolio.
UNI KNR BM
Tags: #Aurobindo Pharma Q2 net profit rises 32.5 pc to Rs 1#124 crore
More News

HDFC Bank authorised to offer deposits under Capital Gains Accounts Scheme

04 Nov 2026 | 11:33 PM

Hyderabad, Nov 4 (UNI) HDFC Bank has received approval from the Government of India to offer deposits under the Capital Gains Accounts Scheme (CGAS), 1988, enabling taxpayers to earn interest while retaining tax exemption benefits on unutilised capital gains, the bank announced on Wednesday.

see more..

NALCO signs technology agreement with EGA for Rs 30,000-Crore smelter expansion project at Anugul

04 Nov 2026 | 9:19 PM

Bhubaneswar, Nov 4 (UNI) In a major boost to Odisha’s industrial growth and India’s aluminium production capacity, National Aluminium Company Limited (NALCO), a Navratna Central Public Sector Enterprise under the Ministry of Mines, Government of India, has entered into an agreement with Emirates Global Aluminium (EGA) for licensing its proprietary aluminium smelting technology for the proposed expansion of its smelter plant at Anugul.

see more..

Apollo Hospitals Q2FY27 net profit rises 32 pc to Rs 630 crore

04 Nov 2026 | 9:10 PM

Hyderabad, Nov 4 (UNI) Apollo Hospitals Enterprise Limited on Wednesday reported a 32 per cent year-on-year growth in consolidated net profit to Rs 630 crore for the second quarter of FY27, compared to the corresponding period last year.

see more..

ISB study warns proposed UPI charges may push street vendors back to cash

04 Nov 2026 | 8:59 PM

Hyderabad, Nov 4 (UNI) A study by the Indian School of Business (ISB) has found that 45 to 53 per cent of surveyed street vendors across different city tiers may reduce their acceptance of Unified Payments Interface (UPI) payments if the proposed Merchant Discount Rate (MDR) charges are implemented.

see more..

Aurobindo Pharma Q2 net profit rises 32 5 pc to Rs 1,124 crore

04 Nov 2026 | 8:29 PM

Hyderabad, Nov 4 (UNI) Aurobindo Pharma Limited on Wednesday reported a 32.5 per cent year-on-year increase in consolidated net profit to Rs 1,124 crore for the second quarter ended September 30, 2026, compared to Rs 848 crore in the corresponding quarter last fiscal.

see more..